Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
1 other identifier
interventional
278
1 country
1
Brief Summary
The investigators overall study objective is to improve patients knowledge and safe use of opioid pain relievers upon discharge from the Emergency Department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 20, 2014
CompletedFirst Posted
Study publicly available on registry
November 24, 2014
CompletedAugust 20, 2019
August 1, 2019
7 months
November 20, 2014
August 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Knowledge of medication name
The primary outcome was the patients ability to identify the medication name of their prescribed opioid pain reliever upon follow-up.
4-7 days
Secondary Outcomes (3)
Knowledge and counseling recall outcomes
4-7 days
Actual Use outcomes
4-7 days
Response to the intervention
4-7 days
Study Arms (2)
Control
NO INTERVENTIONPatients in this arm are discharged from the Northwestern Emergency Department with standard communication about their prescribed opioid pain medication from their care providers. They are called for a follow up survey 4-7 days after their visit.
Dual Modality Educational Intervention
EXPERIMENTALPatients in this arm are discharged from the ED with an additional information sheet about their prescribed opioid pain medication, via the intervention titled "Additional Opioid Information". The sheet is read aloud to them by a research assistant. They are called 4-7 days later for a follow up survey.
Interventions
Patients receiving this intervention are given additional information about the opioid pain medication that they are receiving in the form of a one page handout. The hand out was written in a health-literacy appropriate manner. A research assistant read the handout to them out loud, and they were given a copy to take home with them.
Eligibility Criteria
You may qualify if:
- prescribed an opioid pain reliever
- English Speaking
You may not qualify if:
- Non-English Speaking
- Clinically unstable, psychologically impaired or intoxicated as judged by the research staff member.
- Chronic opioid use, defined as daily or near daily use of opioid pain relievers for the past 90 days.
- admitted to hospital
- unable to complete follow up phone interview in 4 - 7 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- Emergency Medicine Foundationcollaborator
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Danielle McCarthy, MD MS
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Emergency Medicine
Study Record Dates
First Submitted
November 20, 2014
First Posted
November 24, 2014
Study Start
October 1, 2012
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
August 20, 2019
Record last verified: 2019-08